During the past decade, Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 18 clinical trials were completed, i.e. on average, 48.6% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 7 clinical trials were completed. i.e. 29.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS" #1 sponsor was "AIDS Clinical Trials Group" with 17 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 16 trials sponsored, "Oswaldo Cruz Foundation" with 6 trials sponsored, "Butantan Institute" with 3 trials sponsored and "Abbott" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 20 trials as a collaborator, "Gilead Sciences" with 5 trials as a collaborator, "ViiV Healthcare" with 4 trials as a collaborator, "AbbVie" with 2 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS" are "HIV Infections" (23 trials), "HIV Infection" (8 trials), "HIV-1 Infection" (6 trials), "COVID-19" (5 trials) and "Tuberculosis" (5 trials). Many other conditions were trialed in "Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS" in a lesser frequency.

Most popular intervention types in "Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS" are "Drug" (38 trials), "Biological" (12 trials), "Other" (8 trials), "Dietary Supplement" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Efavirenz" (4 trials), "Isoniazid (INH)" (4 trials), "Lamivudine" (4 trials) and "Emtricitabine/Tenofovir disoproxil fumarate" (3 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS" are 50 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 21 active trials in "Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS". 1 are not yet recruiting, 10 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 32 completed trials in Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 4 trials that are defined as “Not Applicable".

Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS has several departments that took part in Clinical trials: "Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation." - 4 trials